Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.980 +0.020 (+1.02%)
Streaming Delayed Price Updated: 12:40 PM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,205
Open 2.010
Bid (Size) 1.980 (200)
Ask (Size) 1.990 (100)
Prev. Close 1.960
Today's Range 1.960 - 2.010
52wk Range 0.5606 - 13.25
Shares Outstanding 596,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
From Enveric Biosciences
Via Business Wire

Performance

YTD
-46.0%
-46.0%
1 Month
+4.2%
+4.2%
3 Month
-48.2%
-48.2%
6 Month
+206.6%
+206.6%
1 Year
+55.9%
+55.9%

More News

Read More
News headline image
Enveric Biosciences Announces Registration of Five Trademarks
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗
Via Stocktwits
Topics Intellectual Property
Why Did ENVB Stock More Than Double In Value Today? ↗
Via Stocktwits
News headline image
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
News headline image
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Why Is ENVB Stock Rising Today? ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Enveric Biosciences Announces Patent Issuance
From Enveric Biosciences
Via Business Wire
News headline image
The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub
Via MarketMinute
Topics Economy Initial Public Offering
News headline image
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
From Enveric Biosciences, Inc
Via Business Wire
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill
News headline image
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 1.980
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 04/13/26 12:40 PM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 1.18M
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.